SCHEMBL960136

SCHEMBL960136

COc1ccc(CCOc2cccc(-c3cccc(C(N)=O)c3)n2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR52 Q9Y2T5 2/20 0.48
PTGDR Q13258 1/20 0.46
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NR1H3 Q13133 1/20 0.45
SYK P43405 1/20 0.44
MAPK1 P28482 3/20 0.43
PGK1 P00558 1/20 0.43
ATR Q13535 1/20 0.43
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
KMT2A Q03164 1/20 0.42
FYN P06241 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
PDE4A P27815 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE4C Q08493 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL957828 0.92 PTGDR (0.55) GPR52PTGDRALDH1A1MAPTKMT2A
SCHEMBL12919048 0.89 GPR52 (0.53) GPR52PTGDRSYKMAPK1ALDH1A1
SCHEMBL962234 0.88 NPC1 (0.49) GPR52PTGDRALDH1A1MAPTTP53
SCHEMBL12919070 0.87 GPR52 (0.54) GPR52PTGDRHDAC1MAPK1MEN1
SCHEMBL964253 0.87 GPR52 (0.56) GPR52PTGDRHDAC1MAPK1MEN1
SCHEMBL12919109 0.87 GPR52 (0.46) GPR52PTGDRHDAC1SYKMAPK1
SCHEMBL12919063 0.86 GPR52 (0.60) GPR52PTGDRMAPK1MEN1ALDH1A1
SCHEMBL12919055 0.86 GPR52 (0.57) GPR52PTGDRMAPK1MEN1ALDH1A1
SCHEMBL959147 0.86 CYP19A1 (0.46) GPR52PTGDRSYKMEN1ALDH1A1
SCHEMBL12919103 0.85 GPR52 (0.50) GPR52PTGDRSYKMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
EP-2253618-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING Takeda Pharmaceutical Company Limited (JP) 2010-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009421-A1 COMPOUND HAVING 6-MEMBERED AROMATIC RING GPR4, NR3C2, NR5A2 GPR52 23/4885PTGDR 528/4885HDAC1 649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.